Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ardent Health Affirms FY2025 GAAP EPS Guidance of $1.73-$2.01 vs $1.92 Est; Affirms FY2025 Sales Guidance of $6.200B-$6.450B vs $6.332B Est

Author: Benzinga Newsdesk | August 05, 2025 03:32pm
Ardent Health (NYSE:ARDT) affirms FY2025 GAAP EPS guidance from $1.73-$2.01 to $1.73-$2.01 vs $1.92 analyst estimate. Affirms FY2025 sales outlook from $6.200 billion-$6.450 billion to $6.200 billion-$6.450 billion vs $6.332 billion estimate.

Posted In: ARDT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist